Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Charles Hicks, MD, is a Professor of Medicine with tenure in the Division of Infectious Diseases at Duke University Medical Center in Durham, North Carolina, USA. He is a graduate of the United States Military Academy at West Point, USA, and the George Washington University School of Medicine, USA, and did his training in Infectious Diseases at Walter Reed Army Medical Center, USA.
He is currently Principal Investigator and Director of the Interdisciplinary Research Training Program in AIDS at Duke and supports the education and training of post-doctoral basic scientists and clinical research fellows training in HIV-related research. He has served on numerous advisory groups and data safety monitoring boards for international studies involving antiretroviral therapy and HIV prevention strategies. He serves as a reviewer for NIH grant proposals and for the research submissions at the International Conference on HIV Infection and the International AIDS Society Pathogenesis Meetings. He is also a reviewer for several infectious diseases and HIV journals.
Dr Hicks also provides HIV patient care in the Duke Infectious Diseases Clinic which cares for over 1800 HIV-infected persons. He is a fellow in the American College of Physicians and in the Infectious Diseases Society of America. He was the recipient of the AB Hoff Memorial Prize Medal and the Bailey K. Ashford Clinical Research Award while at Walter Reed. He has also been awarded the Eugene A. Stead, Jr Award for excellence in teaching by the house staff of the Duke Department of Medicine.
Esteban Martínez studied at the School of Medicine of Valladolid, Spain, from 1980 to 1986. He specialized in Internal Medicine at the Hospital de la Santa Creu i Sant Pau in Barcelona, Spain, from 1988 to 1992, and, in 1996, achieved his PhD from the Autonomous University of Barcelona, Spain, with studies on neurosurgical infections. In 1994, Esteban Martínez started working at the Infectious Diseases Unit of the Hospital Clínic in Barcelona, Spain. Since 1996, he has devoted his time to caring for HIV-infected persons, and, since 2001, he has been teaching infectious diseases at the University of Barcelona as an Associate Professor of Medicine. He is member of the Scientific Board of the International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, has been co-author of the Guidelines for the Prevention and Management of Non-Infectious Co-Morbidities in HIV (European AIDS Clinical Society), and has been a founding member of the International Symposium on Psychiatry and HIV. He is member of the editorial board of The Scientific World Journal and The Open AIDS Journal. His fields of interests span: opportunistic infections (risk of and withdrawal of prophylaxis in the HAART era); simplification of antiretroviral therapy (switch studies); incidence and causes of death in HIV-infected persons receiving antiretroviral therapy, toxicity of antiretrovirals (indinavir-associated nepholitiasis, non-nucleoside-associated hepatitis, risk and management of dyslipemia); lipodystrophy (incidence, diagnosis, risk, and interventions); and non-infectious complications in HIV-infected patients (central nervous system, kidney, bone, and particularly, cardiovascular diseases). He has authored more than 200 papers. He has served as reviewer for major journals on medicine (Lancet, Annals of Internal Medicine, Medicina Clínica), infectious diseases (Clinical Infectious Diseases, Journal of Infectious Diseases, Enfermedades Infecciosas y Microbiología Clínica), chemotherapy (Journal of Antimicrobial Chemotherapy, Antiviral Therapy), and HIV/AIDS (AIDS, JAIDS, HIV Medicine, AIDS Research and Human Retroviruses).
Annemarie M.J. Wensing
Annemarie M.J. Wensing, MD, PhD attained her MSc and MD at the University of Utrecht, the Netherlands. During her post-graduate rotations she became involved in clinical HIV research and care. She was involved in clinical research at the HIV outpatient clinic of the University Medical Center (UMC) Utrecht from 1998 to 2002 and was subsequently trained as a clinical virologist. In 2007 she obtained her PhD on transmission of drug resistant HIV-1. Currently she is Senior Consultant, Virology, at the Department of Virology, Medical Microbiology in the UMC Utrecht. She is the Clinical Supervisor of the HIV laboratory which serves as a WHO reference laboratory. As consultant she advises infectious disease specialists in multiple HIV-centers in their choice of antiretroviral regimens. She teaches virology at the University of Utrecht Medical and Pharmacy School and has organised and/or participated in numerous educational meetings and masterclasses on the clinical management of HIV-resistance. She is a member of the Organising Committee of the HIV-Transmission Workshop. Her research group focuses on transmission and mechanisms of HIV drug-resistance and HIV-tropism. She is CEO and founding member of the European Society of Antiviral Resistance and has been technical coordinator of the successful, European Commission supported, European HIV Resistance and SPREAD Programs, focusing on transmission of HIV-drug resistance. She is a leading member of the European Guidelines panel on clinical management of HIV tropism testing, a member of the WHO HIV Drug Resistance ResNet EWI Expert Advisory Panel, and has recently been welcomed as member of the IAS-USA mutations panel.
Rolf Kaiser, PhD, studied biology at the University of Bonn, Germany, from 1978 to 1985. He completed his PhD in human genetics on molecular analysis of Cystic Fibrosis. In 1990 Dr Kaiser started working as a virologist in the Institute of Medical Microbiology and Immunology, University of Bonn, and since 1999 in the Institute of Virology at the University of Cologne, Germany. Responsibilities in the Institute of Virology, University of Cologne, include viral diagnostics, especially molecular diagnostics.
Starting with cell culture analyses of HIV in Bonn in 1990, by 1991 HIV resistance testing and tropism analysis became the major scientific and diagnostic projects. These scientific projects resulting in diagnostic tools were developed in cooperation with the bioinformatics groups of Thomas Lengauer (at the MPI for Informatics in Saarbrücken) and Daniel Hoffman (University of Duisburg-Essen) and also with clinical partners in Cologne (Mark Oette, Gerd Fätkenheuer), in Düsseldorf (Björn Jensen, Stefan Reuter), in Essen (Stefan Esser) and in Bonn (Jürgen Rockstroh); namely geno2pheno and AREVIR. The activities on HIV resistance and co-receptor usage, as well as HBV and HCV resistance and escape, are coordinated German-wide in HIV-GRADE. Furthermore, a Europe wide initiative supported by EU-funding is EURESIST, which collects HIV-resistance data worldwide and offers an interpretation system through www.euresist.org. All tools are freely available online. Scientific projects investigating the immune system are in cooperation with Jens Verheyen in the Institute of Virology, University of Cologne.